bpc 157 hims Confirmed: The FDA just moved BPC-157 one step closer to compounded access. This could unleash an entirely new revenue stream. $HIMS Hims & Hers stock rises

Hims & Hers stock rises as FDA schedules peptide review Hot button peptides like BPC 157 and TB 500 that are used to speed up muscle recovery or improve sleep may soon become more broadly available to Americans. The products are popular with a group HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer Hims & Hers Stock Jumps as FDA Panel Opens the Door to a Multibillion Dollar Peptide Market PRISM MarketView

SKU: 36939148365 · From iglepidom.org